JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the American Depositary Shares, each representing six ordinary shares, CHF 1.00 per share, nominal value CHF 1.00 per share, of Addex Therapeutics Ltd. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
